Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    May 2018
  1. MAKINO T, Yamasaki M, Tanaka K, Masuike Y, et al
    Metabolic Tumor Volume Change Predicts Long-term Survival and Histological Response to Preoperative Chemotherapy in Locally Advanced Esophageal Cancer.
    Ann Surg. 2018 May 1. doi: 10.1097/SLA.0000000000002808.
    PubMed     Text format     Abstract available


    April 2018
  2. STURM EC, Zahnd WE, Mellinger JD, Ganai S, et al
    Survival Implications of Increased Utilization of Local Excision for cT1N0 Esophageal Cancer.
    Ann Surg. 2018 Apr 18. doi: 10.1097/SLA.0000000000002782.
    PubMed     Text format     Abstract available


    March 2018
  3. KIYOZUMI Y, Baba Y, Okadome K, Yagi T, et al
    IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer.
    Ann Surg. 2018 Mar 27. doi: 10.1097/SLA.0000000000002754.
    PubMed     Text format     Abstract available


    February 2018
  4. LEE SH, Roh JL, Gong G, Cho KJ, et al
    Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.
    Ann Surg. 2018 Feb 16. doi: 10.1097/SLA.0000000000002710.
    PubMed     Text format     Abstract available


    January 2018
  5. XI M, Yang Y, Zhang L, Yang H, et al
    Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes.
    Ann Surg. 2018 Jan 12. doi: 10.1097/SLA.0000000000002670.
    PubMed     Text format     Abstract available


  6. PHILLIPS AW, Dent B, Navidi M, Immanuel A, et al
    Trainee Involvement in Ivor Lewis Esophagectomy Does Not Negatively Impact Outcomes.
    Ann Surg. 2018;267:94-98.
    PubMed     Text format     Abstract available


    December 2017
  7. SONOHARA F, Gao F, Iwata N, Kanda M, et al
    Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2017 Dec 12. doi: 10.1097/SLA.0000000000002622.
    PubMed     Text format     Abstract available


  8. YAGI T, Baba Y, Ishimoto T, Iwatsuki M, et al
    PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer.
    Ann Surg. 2017 Dec 4. doi: 10.1097/SLA.0000000000002616.
    PubMed     Text format     Abstract available


  9. ROBB WB, Maillard E, Mariette C
    Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Implications for the Extent of Lymphadenectomy.
    Ann Surg. 2017;266:e53-e54.
    PubMed     Text format    


  10. TALSMA K, Wijnhoven B, van Lanschot J, van Berge Henegouwen M, et al
    Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer: Post hoc Analysis of a Randomized Controlled Trial.
    Ann Surg. 2017;266:e52-e53.
    PubMed     Text format    


  11. ZHANG YQ, Chen T, Zhang C, Li QL, et al
    Endoscopic Submucosal Dissection for Superficial Proximal Esophageal Neoplasia is Highly Successful.
    Ann Surg. 2017;266:995-999.
    PubMed     Text format     Abstract available


  12. HOANG D, Broer N, Sosa JA, Abitbol N, et al
    Leptin Is Produced by Parathyroid Glands and Stimulates Parathyroid Hormone Secretion.
    Ann Surg. 2017;266:1075-1083.
    PubMed     Text format     Abstract available


  13. SCHNEIDER A, Michaud L, Gottrand F
    Prevalence of Barrett Esophagus in Adolescents and Young Adults With Esophageal Atresia.
    Ann Surg. 2017;266:e96.
    PubMed     Text format    


  14. VERGOUWE FWT, Wijnen RMH, Bruno MJ, Spaander MCW, et al
    Prevalence of Barrett Esophagus in Adolescents and Young Adults With Esophageal Atresia.
    Ann Surg. 2017;266:e95-e96.
    PubMed     Text format    


    November 2017
  15. SEESING MFJ, Gisbertz SS, Goense L, van Hillegersberg R, et al
    A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands.
    Ann Surg. 2017;266:839-846.
    PubMed     Text format     Abstract available


  16. VISSER E, Rossum PSNV, Ruurda JP, Hillegersberg RV, et al
    Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Ann Surg. 2017;266:863-869.
    PubMed     Text format     Abstract available


    August 2017
  17. ELLIOTT JA, Doyle SL, Murphy CF, King S, et al
    Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
    Ann Surg. 2017 Aug 8. doi: 10.1097/SLA.0000000000002398.
    PubMed     Text format     Abstract available


  18. GRAJEK M, Maciejewski A, Giebel S, Krakowczyk L, et al
    First Complex Allotransplantation of Neck Organs: Larynx, Trachea, Pharynx, Esophagus, Thyroid, Parathyroid Glands, and Anterior Cervical Wall: A Case Report.
    Ann Surg. 2017;266:e19-e24.
    PubMed     Text format     Abstract available


  19. STRAATMAN J, van der Wielen N, Cuesta MA, Daams F, et al
    Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial.
    Ann Surg. 2017;266:232-236.
    PubMed     Text format     Abstract available


    July 2017
  20. MANTZIARI S, Gronnier C, Renaud F, Duhamel A, et al
    Survival Benefit of Neoadjuvant Treatment in Clinical T3N0M0 Esophageal Cancer: Results From a Retrospective Multicenter European Study.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002402.
    PubMed     Text format     Abstract available


  21. DEGISORS S, Pasquer A, Renaud F, Behal H, et al
    Are Thoracotomy and/or Intrathoracic Anastomosis Still Predictors of Postoperative Mortality After Esophageal Cancer Surgery?: A Nationwide Study.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002401.
    PubMed     Text format     Abstract available


  22. STEFFEN T, Dietrich D, Schnider A, Kettelhack C, et al
    Recurrence Patterns and Long-Term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002435.
    PubMed     Text format     Abstract available


  23. MARKAR SR, Mackenzie H, Askari A, Faiz O, et al
    Effect of Esophageal Cancer Surgeon Volume on Management and Mortality From Emergency Upper Gastrointestinal Conditions: Population-based Cohort Study.
    Ann Surg. 2017 Jul 12. doi: 10.1097/SLA.0000000000002387.
    PubMed     Text format     Abstract available


  24. MORIS D, Dimitroulis D
    The Comparison of Surgical Approaches in Locally Advanced Esophageal Cancer: Significant Insights but Clinical Fidelity Still to Be Delivered.
    Ann Surg. 2017;266:e11-e12.
    PubMed     Text format    


  25. VISSER E, van Rossum PSN, Verhoeven RHA, Ruurda JP, et al
    Impact of Weekday of Esophagectomy on Short-term and Long-term Oncological Outcomes: A Nationwide Population-based Cohort Study in the Netherlands.
    Ann Surg. 2017;266:76-81.
    PubMed     Text format     Abstract available


  26. ZAIDI AH, Kosovec JE, Matsui D, Omstead AN, et al
    PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat Model.
    Ann Surg. 2017;266:91-98.
    PubMed     Text format     Abstract available


  27. ELLIOTT JA, Docherty NG, Eckhardt HG, Doyle SL, et al
    Weight Loss, Satiety, and the Postprandial Gut Hormone Response After Esophagectomy: A Prospective Study.
    Ann Surg. 2017;266:82-90.
    PubMed     Text format     Abstract available


    June 2017
  28. BARBOUR AP, Cormack OMM, Baker PJ, Hirst J, et al
    Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open Surgery.
    Ann Surg. 2017;265:1158-1165.
    PubMed     Text format     Abstract available


  29. WONG AT, Shao M, Rineer J, Lee A, et al
    The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.
    Ann Surg. 2017;265:1146-1151.
    PubMed     Text format     Abstract available


  30. WILSON MZ, Enomoto LM, Messaris E, Hollenbeak CS, et al
    Misapplication of Statistical Methods May Lead to Misinformation.
    Ann Surg. 2017;265:E78-E79.
    PubMed     Text format    


    May 2017
  31. ROBB WB, Mariette C
    Reply to Letter: "Tumor Response and Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2017;265:e69-e70.
    PubMed     Text format    


  32. ECKER BL, Dempsey DT
    In Response to "Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer".
    Ann Surg. 2017;265:e69.
    PubMed     Text format    


    April 2017
  33. LI B, Hu H, Zhang Y, Zhang J, et al
    Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
    Ann Surg. 2017 Apr 26. doi: 10.1097/SLA.0000000000002280.
    PubMed     Text format     Abstract available


  34. NAKASHIMA Y, Saeki H, Nakanishi R, Sugiyama M, et al
    Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.
    Ann Surg. 2017 Apr 21. doi: 10.1097/SLA.0000000000002252.
    PubMed     Text format     Abstract available


  35. MARKAR SR, Mackenzie H, Lagergren P, Lagergren J, et al
    Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection.
    Ann Surg. 2017 Apr 7. doi: 10.1097/SLA.0000000000002260.
    PubMed     Text format     Abstract available


  36. TALSMA AK, Wijnhoven BP, Steyerberg EW, van Lanschot JJ, et al
    Reply to "Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit".
    Ann Surg. 2017;265:e42-e43.
    PubMed     Text format    


  37. PANDEY D, Pandey R, Garg PK
    Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit.
    Ann Surg. 2017;265:e41-e42.
    PubMed     Text format    


  38. SPEICHER PJ, Englum BR, Ganapathi AM, Wang X, et al
    Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.
    Ann Surg. 2017;265:743-749.
    PubMed     Text format     Abstract available


  39. PHILLIPS AW, Lagarde SM, Navidi M, Disep B, et al
    Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Ann Surg. 2017;265:750-756.
    PubMed     Text format     Abstract available


  40. BANSAL N, Mayilvaganan S
    Primary Hyperparathyroidism With Negative Imaging: A Significant Clinical Problem.
    Ann Surg. 2017;265:e41.
    PubMed     Text format    


    March 2017
  41. MARKAR SR, Mackenzie H, Jemal S, Faiz O, et al
    Emergency Presentation of Esophagogastric Cancer: Predictors and Long-term Prognosis.
    Ann Surg. 2017 Mar 20. doi: 10.1097/SLA.0000000000002224.
    PubMed     Text format     Abstract available


  42. AVERY KN, Chalmers KA, Brookes ST, Blencowe NS, et al
    Development of a Core Outcome Set for Clinical Effectiveness Trials in Esophageal Cancer Resection Surgery.
    Ann Surg. 2017 Mar 10. doi: 10.1097/SLA.0000000000002204.
    PubMed     Text format     Abstract available


  43. SAEKI H, Tsutsumi S, Tajiri H, Yukaya T, et al
    Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2017;265:527-533.
    PubMed     Text format     Abstract available


  44. PASQUALI S, Yim G, Vohra RS, Mocellin S, et al
    Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
    Ann Surg. 2017;265:481-491.
    PubMed     Text format     Abstract available


    February 2017
  45. BABA Y, Yoshida N, Kinoshita K, Iwatsuki M, et al
    Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study.
    Ann Surg. 2017 Feb 1. doi: 10.1097/SLA.0000000000002118.
    PubMed     Text format     Abstract available


  46. CHEN T, Zhou PH, Chu Y, Zhang YQ, et al
    Long-term Outcomes of Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Submucosal Tumors.
    Ann Surg. 2017;265:363-369.
    PubMed     Text format     Abstract available


  47. SHAPIRO J, Biermann K, van Klaveren D, Offerhaus GJ, et al
    Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer.
    Ann Surg. 2017;265:356-362.
    PubMed     Text format     Abstract available


  48. VAN OLPHEN SH, Biermann K, Shapiro J, Wijnhoven BP, et al
    P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy.
    Ann Surg. 2017;265:347-355.
    PubMed     Text format     Abstract available


    January 2017
  49. LOWENFELS AB, Maisonneuve P
    Esophageal Cancer: Long-term Survival and Day of Surgery.
    Ann Surg. 2017 Jan 23. doi: 10.1097/SLA.0000000000001955.
    PubMed     Text format    


  50. SAEKI H, Tsutsumi S, Yukaya T, Tajiri H, et al
    Clinicopathological Features of Cervical Esophageal Cancer: Retrospective Analysis of 63 Consecutive Patients Who Underwent Surgical Resection.
    Ann Surg. 2017;265:130-136.
    PubMed     Text format     Abstract available


  51. RICE TW, Ishwaran H, Hofstetter WL, Schipper PH, et al
    Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.
    Ann Surg. 2017;265:122-129.
    PubMed     Text format     Abstract available


    November 2016
  52. JARGIN SV
    RET/PTC3 Rearrangement in Papillary Thyroid Carcinoma: Possible Marker of Tumor Progression.
    Ann Surg. 2016.
    PubMed     Text format    


  53. BOLLSCHWEILER E, Holscher AH, Herbold T, Metzger R, et al
    Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study.
    Ann Surg. 2016;264:839-846.
    PubMed     Text format     Abstract available


  54. HENEGHAN HM, Donohoe C, Elliot J, Ahmed Z, et al
    Can CT-PET and Endoscopic Assessment Post-Neoadjuvant Chemoradiotherapy Predict Residual Disease in Esophageal Cancer?
    Ann Surg. 2016;264:831-838.
    PubMed     Text format     Abstract available


  55. VAN PUTTEN M, Koeter M, van Laarhoven HW, Lemmens VE, et al
    Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


    October 2016
  56. CAVALLIN F, Scarpa M, Cagol M, Alfieri R, et al
    Esophageal Cancer Clinical Presentation: Trends in the Last 3 Decades in a Large Italian Series.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


    September 2016
  57. GHADBAN T, Reeh M, Koenig AM, Nentwich MF, et al
    Prognostic Significant or Not? The Positive Circumferential Resection Margin in Esophageal Cancer: Impact on Local Recurrence and Overall Survival in Patients Without Neoadjuvant Treatment.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


    August 2016
  58. LAGERGREN J, Mattsson F, Lagergren P
    Reply to Letter: "Esophageal Cancer: Long-term Survival and Day of Surgery".
    Ann Surg. 2016.
    PubMed     Text format    


  59. BURT BM, Groth SS, Sada YH, Farjah F, et al
    Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


    July 2016
  60. HENEGHAN HM, Donohoe C, Elliot J, Ahmed Z, et al
    Can CT-PET and Endoscopic Assessment PostNeoadjuvant Chemoradiotherapy Predict Residual Disease in Esophageal Cancer?
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


  61. PASQUER A, Renaud F, Hec F, Gandon A, et al
    Is Centralization Needed for Esophageal and Gastric Cancer Patients With Low Operative Risk?: A Nationwide Study.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


    June 2016
  62. KATAOKA K, Takeuchi H, Mizusawa J, Igaki H, et al
    Prognostic Impact of Postoperative Morbidity After Esophagectomy for Esophageal Cancer: Exploratory Analysis of JCOG9907.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


    April 2016
  63. MAMIDANNA R, Ni Z, Anderson O, Spiegelhalter SD, et al
    Surgeon Volume and Cancer Esophagectomy, Gastrectomy, and Pancreatectomy: A Population-based Study in England.
    Ann Surg. 2016;263:727-32.
    PubMed     Text format     Abstract available


    March 2016
  64. SPEICHER PJ, Englum BR, Ganapathi AM, Wang X, et al
    Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


  65. SAEKI H, Tsutsumi S, Tajiri H, Yukaya T, et al
    Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


    February 2016
  66. MARET-OUDA J, Konings P, Lagergren J, Brusselaers N, et al
    Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
    Ann Surg. 2016;263:251-7.
    PubMed     Text format     Abstract available


  67. IN H, Palis BE, Merkow RP, Posner MC, et al
    Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement.
    Ann Surg. 2016;263:286-91.
    PubMed     Text format     Abstract available


    January 2016
  68. MORIS D, Dimitroulis D
    The Comparison of Surgical Approaches in Locally Advanced Esophageal Cancer: Significant Insights but Clinical Fidelity Still to Be Delivered.
    Ann Surg. 2016.
    PubMed     Text format    


  69. SAEKI H, Tsutsumi S, Yukaya T, Tajiri H, et al
    Clinicopathological Features of Cervical Esophageal Cancer: Retrospective Analysis of 63 Consecutive Patients Who Underwent Surgical Resection.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


  70. RICE TW, Ishwaran H, Hofstetter WL, Schipper PH, et al
    Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.
    Ann Surg. 2016.
    PubMed     Text format     Abstract available


  71. LIU K, Yang K, Zhang W, Chen X, et al
    Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-institution, High-volume Experience in China.
    Ann Surg. 2016;263:88-95.
    PubMed     Text format     Abstract available


    December 2015
  72. BABA Y, Yoshida N, Shigaki H, Iwatsuki M, et al
    Prognostic Impact of Postoperative Complications in 502 Patients With Surgically Resected Esophageal Squamous Cell Carcinoma: A Retrospective Single Institution Study.
    Ann Surg. 2015.
    PubMed     Text format     Abstract available


  73. MEHDORN AS, Palmes D, Dhayat S
    Effect of Simvastatin on Physiological and Biological Outcomes in Patients Undergoing Esophagectomy.
    Ann Surg. 2015;262:e119.
    PubMed     Text format    


  74. CAVALLIN F, Scarpa M, Alfieri R, Cagol M, et al
    The Role of Surgery in Patients With a Complete Clinical Response After Chemoradiation for Esophageal Cancer.
    Ann Surg. 2015;262:e101.
    PubMed     Text format    


  75. SHYAMSUNDAR M, McAuley DF, O'Kane CM
    Reply to Letter: "Effect of Simvastatin on Physiological and Biological Outcomes in Patients Undergoing Esophagectomy: A Randomized Placebo-controlled Trial".
    Ann Surg. 2015;262:e95-6.
    PubMed     Text format    


  76. BATTERSBY CL, Bryan N, Hunt JA
    Effect of Simvastatin on Physiological and Biological Outcomes in Patients Undergoing Esophagectomy: A Randomized Placebo-controlled Trial.
    Ann Surg. 2015;262:e95.
    PubMed     Text format    


  77. MARIETTE C, Robb WB, Piessen G
    Reply to Letter: "The Role of Surgery for Patients With a Complete Clinical Response After Chemoradiation for Esophageal Cancer".
    Ann Surg. 2015;262:e101-2.
    PubMed     Text format    


  78. MARKAR S, Gronnier C, Duhamel A, Mabrut JY, et al
    The Impact of Severe Anastomotic Leak on Long-term Survival and Cancer Recurrence After Surgical Resection for Esophageal Malignancy.
    Ann Surg. 2015;262:972-80.
    PubMed     Text format     Abstract available


  79. KUMAR S, Huang J, Abbassi-Ghadi N, Mackenzie HA, et al
    Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
    Ann Surg. 2015;262:981-90.
    PubMed     Text format     Abstract available


    November 2015
  80. HWANG JY, Chen HS, Hsu PK, Chao YK, et al
    A Propensity-matched Analysis Comparing Survival After Esophagectomy Followed by Adjuvant Chemoradiation to Surgery Alone for Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2015.
    PubMed     Text format     Abstract available


  81. ROBB WB, Maillard E, Mariette C
    Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Implications for the Extent of Lymphadenectomy.
    Ann Surg. 2015.
    PubMed     Text format    


  82. LAGERGREN J, Mattsson F, Lagergren P
    Weekday of Esophageal Cancer Surgery and Its Relation to Prognosis.
    Ann Surg. 2015.
    PubMed     Text format     Abstract available


  83. MESSAGER M, Pasquer A, Duhamel A, Caranhac G, et al
    Laparoscopic Gastric Mobilization Reduces Postoperative Mortality After Esophageal Cancer Surgery: A French Nationwide Study.
    Ann Surg. 2015;262:817-823.
    PubMed     Text format     Abstract available


  84. ELLIOTT JA, Jackson S, King S, McHugh R, et al
    Gut Hormone Suppression Increases Food Intake After Esophagectomy With Gastric Conduit Reconstruction.
    Ann Surg. 2015;262:824-29.
    PubMed     Text format     Abstract available


  85. NAFTEUX PR, Lerut AM, Moons J, Holscher AH, et al
    International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems.
    Ann Surg. 2015;262:809-15.
    PubMed     Text format     Abstract available


  86. HENEGHAN HM, Zaborowski A, Fanning M, McHugh A, et al
    Prospective Study of Malabsorption and Malnutrition After Esophageal and Gastric Cancer Surgery.
    Ann Surg. 2015;262:803-808.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: